Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Cited In for PubMed (Select 21876127)

1.

NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases.

Abderrazak A, Syrovets T, Couchie D, El Hadri K, Friguet B, Simmet T, Rouis M.

Redox Biol. 2015 Apr;4C:296-307. doi: 10.1016/j.redox.2015.01.008. Epub 2015 Jan 14. Review.

2.

Adipose tissue as an immunological organ.

Grant RW, Dixit VD.

Obesity (Silver Spring). 2015 Mar;23(3):512-8. doi: 10.1002/oby.21003. Epub 2015 Jan 22.

PMID:
25612251
3.

Reactive Oxygen Species-Induced TXNIP Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through NLRP3 Inflammasome Activation.

Zhang X, Zhang JH, Chen XY, Hu QH, Wang MX, Jin R, Zhang QY, Wang W, Wang R, Kang LL, Li JS, Li M, Pan Y, Huang JJ, Kong LD.

Antioxid Redox Signal. 2015 Apr 1;22(10):848-70. doi: 10.1089/ars.2014.5868.

PMID:
25602171
4.

Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.

Patel MN, Bernard WG, Milev NB, Cawthorn WP, Figg N, Hart D, Prieur X, Virtue S, Hegyi K, Bonnafous S, Bailly-Maitre B, Chu Y, Griffin JL, Mallat Z, Considine RV, Tran A, Gual P, Takeuchi O, Akira S, Vidal-Puig A, Bennett MR, Sethi JK.

Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):506-11. doi: 10.1073/pnas.1414536112. Epub 2014 Dec 24.

PMID:
25540417
5.

Mitochondria: diversity in the regulation of the NLRP3 inflammasome.

Gurung P, Lukens JR, Kanneganti TD.

Trends Mol Med. 2015 Mar;21(3):193-201. doi: 10.1016/j.molmed.2014.11.008. Epub 2014 Nov 27. Review.

PMID:
25500014
7.

Inflammasomes in neuroinflammation and changes in brain function: a focused review.

Singhal G, Jaehne EJ, Corrigan F, Toben C, Baune BT.

Front Neurosci. 2014 Oct 7;8:315. doi: 10.3389/fnins.2014.00315. eCollection 2014. Review.

8.

Obesity in kidney disease: A heavyweight opponent.

Felizardo RJ, da Silva MB, Aguiar CF, Câmara NO.

World J Nephrol. 2014 Aug 6;3(3):50-63. doi: 10.5527/wjn.v3.i3.50. Review.

9.

Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases.

Guo B, Li Z.

Front Genet. 2014 Jul 25;5:242. doi: 10.3389/fgene.2014.00242. eCollection 2014. Review.

10.

Linking obesity with type 2 diabetes: the role of T-bet.

Wali JA, Thomas HE, Sutherland AP.

Diabetes Metab Syndr Obes. 2014 Jul 22;7:331-40. doi: 10.2147/DMSO.S51432. eCollection 2014. Review.

11.

Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy.

Shahzad K, Bock F, Dong W, Wang H, Kopf S, Kohli S, Al-Dabet MM, Ranjan S, Wolter J, Wacker C, Biemann R, Stoyanov S, Reymann K, Söderkvist P, Groß O, Schwenger V, Pahernik S, Nawroth PP, Gröne HJ, Madhusudhan T, Isermann B.

Kidney Int. 2015 Jan;87(1):74-84. doi: 10.1038/ki.2014.271. Epub 2014 Jul 30.

12.

High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.

Ganz M, Csak T, Szabo G.

World J Gastroenterol. 2014 Jul 14;20(26):8525-34. doi: 10.3748/wjg.v20.i26.8525.

13.

Transcriptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation.

Yin Z, Deng T, Peterson LE, Yu R, Lin J, Hamilton DJ, Reardon PR, Sherman V, Winnier GE, Zhan M, Lyon CJ, Wong ST, Hsueh WA.

Mol Cell Endocrinol. 2014 Aug 25;394(1-2):80-7. doi: 10.1016/j.mce.2014.06.018. Epub 2014 Jul 7.

PMID:
25011057
14.

The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?

Kahlenberg JM, Kaplan MJ.

Curr Opin Rheumatol. 2014 Sep;26(5):475-81. doi: 10.1097/BOR.0000000000000088.

PMID:
24992143
15.

Maternal obesity, inflammation, and developmental programming.

Segovia SA, Vickers MH, Gray C, Reynolds CM.

Biomed Res Int. 2014;2014:418975. doi: 10.1155/2014/418975. Epub 2014 May 20. Review.

16.

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease.

Miura K, Ohnishi H.

World J Gastroenterol. 2014 Jun 21;20(23):7381-91. doi: 10.3748/wjg.v20.i23.7381. Review.

17.

Inflammasomes: molecular regulation and implications for metabolic and cognitive diseases.

Choi AJ, Ryter SW.

Mol Cells. 2014 Jun;37(6):441-8. doi: 10.14348/molcells.2014.0104. Epub 2014 May 19. Review.

18.

Beyond canonical inflammasomes: emerging pathways in IL-1-mediated autoinflammatory disease.

Lukens JR, Kanneganti TD.

Semin Immunopathol. 2014 Sep;36(5):595-609. doi: 10.1007/s00281-014-0434-8. Epub 2014 May 17.

PMID:
24838628
19.

Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation.

Zhao C, Gillette DD, Li X, Zhang Z, Wen H.

J Biol Chem. 2014 Jun 13;289(24):17020-9. doi: 10.1074/jbc.M114.563114. Epub 2014 May 5.

PMID:
24798340
20.

Role of innate immune response in non-alcoholic Fatty liver disease: metabolic complications and therapeutic tools.

Meli R, Mattace Raso G, Calignano A.

Front Immunol. 2014 Apr 23;5:177. doi: 10.3389/fimmu.2014.00177. eCollection 2014. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk